These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23790022)

  • 1. Anti-cancer properties of triterpenoids isolated from Ganoderma lucidum - a review.
    Wu GS; Guo JJ; Bao JL; Li XW; Chen XP; Lu JJ; Wang YT
    Expert Opin Investig Drugs; 2013 Aug; 22(8):981-92. PubMed ID: 23790022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of the molecular mechanisms of Ganoderma lucidum triterpenoids: Ganoderic acids A, C2, D, F, DM, X and Y.
    Liang C; Tian D; Liu Y; Li H; Zhu J; Li M; Xin M; Xia J
    Eur J Med Chem; 2019 Jul; 174():130-141. PubMed ID: 31035236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-tumor target prediction and activity verification of Ganoderma lucidum triterpenoids].
    Du GH; Wang HX; Yan Z; Liu LY; Chen RY
    Zhongguo Zhong Yao Za Zhi; 2017 Feb; 42(3):517-522. PubMed ID: 28952258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3.
    Jiang J; Slivova V; Valachovicova T; Harvey K; Sliva D
    Int J Oncol; 2004 May; 24(5):1093-9. PubMed ID: 15067330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terpenoids: natural products for cancer therapy.
    Huang M; Lu JJ; Huang MQ; Bao JL; Chen XP; Wang YT
    Expert Opin Investig Drugs; 2012 Dec; 21(12):1801-18. PubMed ID: 23092199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities.
    Xu Z; Chen X; Zhong Z; Chen L; Wang Y
    Am J Chin Med; 2011; 39(1):15-27. PubMed ID: 21213395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular docking based screening of triterpenoids as potential G-quadruplex stabilizing ligands with anti-cancer activity.
    Sillapapongwarakorn S; Yanarojana S; Pinthong D; Thithapandha A; Ungwitayatorn J; Supavilai P
    Bioinformation; 2017; 13(9):284-292. PubMed ID: 29081607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic triterpenoids from Ganoderma lucidum.
    Cheng CR; Yue QX; Wu ZY; Song XY; Tao SJ; Wu XH; Xu PP; Liu X; Guan SH; Guo DA
    Phytochemistry; 2010 Sep; 71(13):1579-85. PubMed ID: 20615519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor-dependent and -independent mechanisms mediate Ganoderma lucidum activities in LNCaP prostate cancer cells.
    Zaidman BZ; Wasser SP; Nevo E; Mahajna J
    Int J Oncol; 2007 Oct; 31(4):959-67. PubMed ID: 17786330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganoderma lucidum: A rational pharmacological approach to surmount cancer.
    Ahmad MF
    J Ethnopharmacol; 2020 Oct; 260():113047. PubMed ID: 32504783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study progress on triterpenoids from Ganoderma lucidum].
    Li Y; Zhu Z; Yao W; Chen R
    Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(2):165-71. PubMed ID: 22737844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triterpenoids from Ganoderma lucidum and their cytotoxic activities.
    Li P; Deng YP; Wei XX; Xu JH
    Nat Prod Res; 2013; 27(1):17-22. PubMed ID: 22263904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-kappaB signaling.
    Jiang J; Slivova V; Harvey K; Valachovicova T; Sliva D
    Nutr Cancer; 2004; 49(2):209-16. PubMed ID: 15489214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganoderma lucidum exerts anti-tumor effects on ovarian cancer cells and enhances their sensitivity to cisplatin.
    Zhao S; Ye G; Fu G; Cheng JX; Yang BB; Peng C
    Int J Oncol; 2011 May; 38(5):1319-27. PubMed ID: 21399867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihepatoma activity of the acid and neutral components from Ganoderma lucidum.
    Lu H; Song J; Jia XB; Feng L
    Phytother Res; 2012 Sep; 26(9):1294-300. PubMed ID: 22275242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lanostanoids from fungi: a group of potential anticancer compounds.
    Ríos JL; Andújar I; Recio MC; Giner RM
    J Nat Prod; 2012 Nov; 75(11):2016-44. PubMed ID: 23092389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of antiproliferative activities and action mechanisms of extracts from two species of Ganoderma on tumor cell lines.
    Liu YW; Gao JL; Guan J; Qian ZM; Feng K; Li SP
    J Agric Food Chem; 2009 Apr; 57(8):3087-93. PubMed ID: 19368349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer properties of Ganoderma lucidum methanol extracts in vitro and in vivo.
    Harhaji Trajković LM; Mijatović SA; Maksimović-Ivanić DD; Stojanović ID; Momcilović MB; Tufegdzić SJ; Maksimović VM; Marjanović ZS; Stosić-Grujicić SD
    Nutr Cancer; 2009; 61(5):696-707. PubMed ID: 19838944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganoderma lucidum for cancer treatment: we are close but still not there.
    Cheng S; Sliva D
    Integr Cancer Ther; 2015 May; 14(3):249-57. PubMed ID: 25626896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ganoderma lucidum (Reishi) in cancer treatment.
    Sliva D
    Integr Cancer Ther; 2003 Dec; 2(4):358-64. PubMed ID: 14713328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.